Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis

Haematologica

Volumn 83, Issue 7, 1998, Pages 593-601

  Martinelli, Giovanni ^a,d   Testoni, Nicoletta ^a   Montefusco, Vittorio ^a   Amabile, Marilina ^a   Saglio, Giuseppe ^b   Ottaviani, Emanuela ^a   Terragna, Carolina ^a   Bonifazzi, Francesca ^a   De Vivo, Antonio ^a   Pane, Fabrizio ^c   Rosti, Gianantonio ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Capillary electrophoresis; Chronic myelogenous leukemia; RT PCR

Indexed keywords

BCR ABL PROTEIN; RNA;

ADULT; AGED; ARTICLE; CAPILLARY ELECTROPHORESIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; ELECTROPHORESIS, CAPILLARY; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031903304     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gelfi C, Leoncini F, Righetti PG, et al. Separation and quantitation of reverse transcriptase polymerase chain reaction fragments of basic fibroblast growth factor by capillary electrophoresis in polymer networks. Electrophoresis 1995; 16:780-3.
2. Kuypers AW, Meijerink JP, Smetsers TF, Linssen PC, Mensink EJ. Quantitative analysis of DNA aberrations amplified by competitive polymerase chain reaction using capillary electrophoresis. J Chromatogr B Biomed Sci Appl 1994; 660:271-7.
3. Karger BL, Chu YH, Foret F. Capillary electrophoresis of proteins and nucleic acids. Annu Rev Biophys Biomol Struct 1995; 24:579-610.
4. Felmlee TA, Oda RP, Persing DA, Landers JP. Capillary electrophoresis of DNA potential utility for clinical diagnoses. J Chromatogr A 1995; 717:127-37.
5. Nathakarnkitkool S, Oefner PJ, Bartsch G, Chin MA, Bonn GK. High-resolution capillary electrophoretic analysis of DNA in free solution. Electrophoresis 1992; 13:18-31.
6. Guo JQ, Lian JY, Xian YM, et al. Bcr-abl protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy. Blood 1994; 83:3629-37.
7. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 24:290-5.
8. Lifshitz B, Fainstein E, Marcelle C, et al. Bcr genes and transcripts. Oncogene 1988; 2:113-7.
9. Shtivelman E, Gale RP, Dreazen O, et al. Bcr-abl RNA in patients with chronic myelogenous leukemia. Blood 1987; 69:971-5.
10. Melo JV, Gordon DE, Cross NC, Goldman JM. The abl-bcr fusion gene is expressed in chronic myeloid leukemia. Blood 1993; 81:158-65.
11. Hughes TP, Morgan GJ, Martiat P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991; 77:874-8.
12. Morgan GJ, Hughes T, Janssen JW, et al. Polymerase chain reaction for detection of residual leukaemia. Lancet 1989; 1:928-9.
13. Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte ON, Champlin R. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by the polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87:563-7.
14. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myeloid leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108:806-14.
15. Guerrasio A, Martinelli G, Saglio G, et al. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants. Leukemia 1992; 6:507-12.
16. Martinelli G, Zaccaria A, Farabegoli P, et al. Structural organization of bcr-abl gene in chronic phase and blast transformation in chronic myeloid leukemia patients. Leuk Lymphoma 1993; 11:51-6.
17. Frassoni F, Martinelli G, Saglio G, et al. Bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase. Bone Marrow Transplant 1995; 16:595-601.
18. Cross NC. Quantitative PCR techniques and applications. Br J Haematol 1995; 89:693-7.
19. Thompson JD, Brodsky I, Yunis JJ. Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation. Blood 1992; 79:1629-35.
20. Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM. Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82:1929-36.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
22. Testoni N, Martinelli G, Farabegoli P, et al. A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of bcr/abl transcript in chronic myeloid leukemia patients. Blood 1996; 87:3822-7.
23. Zaccaria A, Martinelli G, Buzzi M, Farabegoli P. Will molecular biology contribute to refine prognosis and to select treatment? Leuk Lymphoma 1993; 11:81-9.
24. Martinelli G, Gasparini P, Ambrosetti A, Battista R, Perona G, Pignatti PF. Molecular genetic analysis of bcr breakpoint in Philadelphia chromosome rearrangements and correlation with prognosis and age of chronic myelogenous leukaemia patients. In: Bartsocas CS, Loukopoulos D, eds. Genetics of hematological disorders. Washington: Hemisphere Publishing Corp.; 1990. p. 185.
25. Santini V, Zoccolante A, Bosi A, et al. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation. Haematologica 1996; 81:201-7.
26. Anonymous. Treatment of the individual patient with chronic myelogenous leukemia. Haematologica 1997; 82:385-6.
27. Carella AM, Frassoni F, Melo J, et al. New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica 1997; 82:478-95.
28. Stewart MJ, Cox G, Reifel-Miller A, Kim SY, Westbrook CA, Leibowitz DS. A novel transcriptional suppressor located within a downstream intron of the BCR gene. J Biol Chem 1994; 269:10820-9.
29. Leibowitz D, Young K, Cox G. Sequence-specific DNA-binding proteins within the Mbcr on the Ph1 chromosome. Genes Chromosomes Cancer 1991; 3:308-12.
30. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Chronic myeloid leukemia, bcr-abl transcript, response to α-interferon and survival. Leukemia 1995; 9:1648-52.